That's why, after extensive review, BARDA has begun the process of terminating these 22 contracts, totaling just under $500 million, to replace the troubled MRNA programs. We're prioritizing the development of safer, broader vaccine strategies, like whole virus vaccines and novel platforms. that don't collapse when viruses mutate. Let me be absolutely clear. HHS supports safe, effective vaccines for every American who wants them. (01:57–02:06)
CLAIM
Asserts that HHS is prioritizing safer vaccine strategies over MRNA.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
